Lumina Fund Management’s VanEck Biotech ETF BBH Stock Holding History

Lumina Fund Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-64,400	Closed	-$3.7M	–	46
2016 Q1	$3.7M	Hold	64,400	–	–	0.44%	15
2015 Q4	$4.21M	Hold	64,400	–	–	0.36%	13
2015 Q3	$4.05M	Hold	64,400	–	–	0.31%	17
2015 Q2	$4.56M	Hold	64,400	–	–	0.28%	19
2015 Q1	$4.52M	Hold	64,400	–	–	0.5%	10
2014 Q4	$4.14M	Hold	64,400	–	–	0.35%	18
2014 Q3	$4.09M	Hold	64,400	–	–	0.38%	20
2014 Q2	$4M	Hold	64,400	–	–	0.19%	20
2014 Q1	$3.76M	Hold	64,400	–	–	0.44%	26
2013 Q4	$3.42M	Hold	64,400	–	–	0.35%	30
2013 Q3	$3.08M	Hold	64,400	–	–	0.26%	23
2013 Q2	$2.93M	Buy	+64,400	New	+$4.48M	0.19%	20

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $3.51B AUM 13.98% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Lumina Fund Management's BBH Position: Q2 2016 in Review

Lumina Fund Management sold out of VanEck Biotech ETF (BBH) in Q2 2016, closing a stake of 64,400 shares — an estimated $3.7M sold.

Lumina Fund Management first reported a position in BBH in Q2 2013 and held it in 12 quarters. The position peaked at $4.56M in Q2 2015. 78 funds tracked by Wall St. Rank hold BBH as of Q2 2016.

Lumina Fund Management reported no remaining VanEck Biotech ETF position as of Q2 2016 after selling out during the quarter.
Lumina Fund Management sold 64,400 VanEck Biotech ETF shares in Q2 2016, an estimated $3.7M.
Lumina Fund Management first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 12 quarters.
Lumina Fund Management's VanEck Biotech ETF position peaked at $4.56M in Q2 2015.
78 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2016.

Based on Lumina Fund Management's 13F filing for Q2 2016, filed 12 Aug 2016.